Is a paradigm shift in US healthcare reimbursement inevitable?

Circulation. 2004 Mar 30;109(12):1456-9. doi: 10.1161/01.CIR.0000124796.68046.66.
No abstract available

MeSH terms

  • Cost Control
  • Costs and Cost Analysis
  • Delivery of Health Care*
  • Diffusion of Innovation*
  • Drug Costs
  • Equipment and Supplies / economics
  • Equipment and Supplies / supply & distribution
  • Forecasting
  • Health Care Costs
  • Health Care Rationing
  • Health Policy
  • Humans
  • Insurance, Health, Reimbursement / trends*
  • Medical Laboratory Science / economics
  • Models, Theoretical
  • United States